Literature DB >> 420995

Tumour antigens and optimism.

.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 420995      PMCID: PMC1597637     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  11 in total

1.  Active specific immunotherapy of human solid tumors.

Authors:  F E Rosato
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  Adjuvant immuno- and/or chemotherapy with neuraminidase-treated autogenous tumor vaccine and Bacillus Calmette-Guérin for head and neck cancers.

Authors:  T J Cunningham; R Antemann; D Paonessa; R W Sponzo; D Steiner
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

3.  Neuraminidase immunotherapy of tumors in man.

Authors:  F E Rosato; A S Brown; E E Miller; E F Rosato; W F Mullis; J Johnson; A Moskovitz
Journal:  Surg Gynecol Obstet       Date:  1974-11

Review 4.  Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.

Authors:  J U Gutterman; G Mavligit; R Reed; S Richman; C E McBride; E M Hersh
Journal:  Semin Oncol       Date:  1975-06       Impact factor: 4.929

5.  Immunotherapy of malignancy in humans. Current status.

Authors:  E C Holmes; F R Eilber; D L Morton
Journal:  JAMA       Date:  1975-06-09       Impact factor: 56.272

6.  Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.

Authors:  G A Currie; F Lejeune; G H Fairley
Journal:  Br Med J       Date:  1971-05-08

7.  Immunotherapy of osteosarcoma patients with virus-modified tumor cells.

Authors:  A A Green; C Pratt; R G Webster; K Smith
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

8.  Active specific immunotherapy of human solid tumors.

Authors:  F E Rosato; E Miller; E F Rosato
Journal:  Va Med       Date:  1978-03

9.  Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.

Authors:  D W Hedley; T J McElwain; G A Currie
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

10.  Effect of active immunization with irradiated tumour cells on specific serum inhibitors of cell-mediated immunity in patients with disseminated cancer.

Authors:  G A Currie
Journal:  Br J Cancer       Date:  1973-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.